Consensus Estimates and Trading Data for Second Sight Medical Products, Inc. (EYES)

In the past 52-week period, shares of Second Sight Medical Products, Inc. (NASDAQ:EYES) have moved within the range of $0.90 to $2.83. On the stock’s most recent trading day, the company’s shares ended the regular session at $1.36, which is 51.94% higher than its 52-week high.

Second Sight Medical Products, Inc. (EYES) has demonstrated a 20-day simple moving average (SMA) of 13.81%, and a 50-day SMA of 16.55%. This public company’s current market capitalization stands at $82.93 million.

Analyzing Consensus Estimates, Sales Revenue and Net Income

Checking the amount of enthusiasm that Wall Street analysts hold for a particular stock is crucial when thinking about entering a position. According to the latest data, the consensus recommendation for Second Sight Medical Products, Inc. (EYES) is Outperform.

Public companies normally post earnings and revenue results that fall somewhat above or below the average Wall Street estimate. In the most recent quarterly financial report, for the quarter ending Jun. 2017, Second Sight Medical Products, Inc. (EYES) delivered a 56.36% surprise with its net revenue.

Meanwhile, during the same quarter Second Sight Medical Products, Inc. (EYES) delivered a -20.00% earnings surprise. Net earnings for the quarter were posted at -$0.12 per share, whereas Wall Street had forecast -$0.15 per share.

Ownership at Second Sight Medical Products, Inc. (EYES), According to Most Recent SEC Filings

A publicly-traded organization’s latest 13F filings tell us important details about its institutional ownership. Second Sight Medical Products, Inc. (EYES) has 0 billion shares outstanding currently, 15.84% of which belong to institutional investors. Those institutional holdings amount to $0.01 billion.

Additionally, according to the most recent 13F filing from Second Sight Medical Products, Inc. (EYES), there were 10 new positions totaling 1,504,548 shares of the company’s stock. There were 9 sold out positions, on the other hand, totaling 391,528 shares.

Short, Medium and Long Term Indicators

Assessing the average trade volume of a public company’s stock in the short, medium and long term is helpful to gain an understanding of trading activity and investor sentiment. Second Sight Medical Products, Inc. (EYES) has had a 20-day average volume of 531,415 shares, with an average of 100% of short term indicators pointed at Buy.

The stock’s 50-day average volume has been 456,970 shares, with an average of 50% of medium term indicators pointing toward Buy. Finally, its 100-day average volume is 373,786 shares with 100% of long-term indicators pointing to Buy.